• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

一种旧分子的新化学性质:顺式-[铂(Ⅱ)氨氯络合物]

New chemistry of an old molecule: cis-[Pt(NH3)2Cl2].

作者信息

Lippard S J

出版信息

Science. 1982 Dec 10;218(4577):1075-82. doi: 10.1126/science.6890712.

DOI:10.1126/science.6890712
PMID:6890712
Abstract

The discovery that cis-diamminedichloroplatinum(II) (cis-DDP) has clinically useful antitumor properties and can form platinum blues spawned an extensive investigation of its chemistry in water. Several new molecules have been synthesized, some rather old ones have been characterized for the first time, and clues have begun to emerge about the chemical interaction of cis-DDP with its likely biological target, DNA.

摘要

顺二氯二氨合铂(II)(顺铂)具有临床可用的抗肿瘤特性且能形成铂蓝这一发现,引发了对其在水中化学性质的广泛研究。几种新分子已被合成,一些相当古老的分子也首次得到了表征,并且关于顺铂与其可能的生物靶点DNA的化学相互作用的线索已开始显现。

相似文献

1
New chemistry of an old molecule: cis-[Pt(NH3)2Cl2].一种旧分子的新化学性质:顺式-[铂(Ⅱ)氨氯络合物]
Science. 1982 Dec 10;218(4577):1075-82. doi: 10.1126/science.6890712.
2
DNA-platinum interactions in vitro with trans- and cis-Pt(NH3)2Cl2.体外DNA与反式和顺式Pt(NH₃)₂Cl₂的相互作用。
Bioinorg Chem. 1975;5(1):59-66. doi: 10.1016/s0006-3061(00)80221-5.
3
Trans-diammineplatinum(II): what makes it different from cis-DDP? Coordination chemistry of a neglected relative of cisplatin and its interaction with nucleic acids.反式二氨合铂(II):它与顺铂有何不同?顺铂一个被忽视的同类物的配位化学及其与核酸的相互作用。
Met Ions Biol Syst. 1996;33:105-41.
4
Adducts of the antitumor drug cis-diamminedichloroplatinum(II) with DNA: formation, identification, and quantitation.抗肿瘤药物顺式二氨二氯铂(II)与DNA的加合物:形成、鉴定及定量分析
Biochemistry. 1985 Jan 29;24(3):707-13. doi: 10.1021/bi00324a025.
5
Interaction of the antitumor agents cis,cis,trans-PtIV(NH3)2Cl2(OH)2 and cis,cis,trans-PtIV[(CH3)2CHNH2]2Cl2(OH)2 and their reduction products with PM2 DNA.
Biochemistry. 1984 Oct 9;23(21):4817-20. doi: 10.1021/bi00316a001.
6
Studies of the binding interactions of cis-diamminedichloroplatinum(II) with amines and nucleosides by nitrogen-15 nuclear magnetic resonance.通过氮-15核磁共振研究顺二氯二氨合铂(II)与胺类和核苷的结合相互作用。
Biochemistry. 1982 Sep 28;21(20):4920-6. doi: 10.1021/bi00263a014.
7
Modulation of platinum antitumor drug binding to DNA by linked and free intercalators.
Biochemistry. 1986 May 20;25(10):3031-8. doi: 10.1021/bi00358a044.
8
Similar binding of the carcinostatic drugs cis-[Pt(NH3)2Cl2] and [Ru(NH3)5Cl] Cl2 to tRNAphe and a comparison with the binding of the inactive trans-[Pt(NH3)2Cl2] complex - reluctance in binding to Watson-Crick base pairs within double helix.抗癌药物顺式-[Pt(NH₃)₂Cl₂]和[Ru(NH₃)₅Cl]Cl₂与苯丙氨酸转运核糖核酸(tRNAphe)的类似结合以及与无活性的反式-[Pt(NH₃)₂Cl₂]配合物结合情况的比较——在双螺旋结构中与沃森-克里克碱基对结合的迟缓性
Nucleic Acids Res. 1983 Sep 24;11(18):6571-86. doi: 10.1093/nar/11.18.6571.
9
The reaction of Pt-antitumor drugs with selected nucleophiles. I. The reaction of cis-[Pt(NH3)2Cl2] with glycine.
J Inorg Biochem. 1985 Jan;23(1):43-53. doi: 10.1016/0162-0134(84)85004-7.
10
Dissociation of double-stranded poly(I) . poly(C) by cis-diammine-dichloro-Pt(II).
Biochim Biophys Acta. 1979 Oct 25;564(3):456-72. doi: 10.1016/0005-2787(79)90036-4.

引用本文的文献

1
Clinical Use of Cisplatin Liposomes for Patients With Refractory Advanced Cancer.顺铂脂质体在难治性晚期癌症患者中的临床应用
Cureus. 2024 Nov 6;16(11):e73181. doi: 10.7759/cureus.73181. eCollection 2024 Nov.
2
Future investigative directions for novel therapeutic targets in head and neck cancer.头颈部癌症新型治疗靶点的未来研究方向。
Expert Rev Anticancer Ther. 2024 Nov;24(11):1067-1084. doi: 10.1080/14737140.2024.2417038. Epub 2024 Oct 16.
3
Improved efficacy of cisplatin delivery by peanut agglutinin‑modified liposomes in non‑small cell lung cancer.
花生凝集素修饰脂质体提高顺铂在非小细胞肺癌中的疗效。
Int J Mol Med. 2024 Aug;54(2). doi: 10.3892/ijmm.2024.5394. Epub 2024 Jul 4.
4
Optical modulation of cell nucleus penetration and singlet oxygen release of a switchable platinum complex.可切换铂配合物的细胞核穿透及单线态氧释放的光调制
iScience. 2023 Dec 9;27(1):108704. doi: 10.1016/j.isci.2023.108704. eCollection 2024 Jan 19.
5
Synthesis, Physicochemical Characterization, Biological Evaluation, In Silico and Molecular Docking Studies of Pd(II) Complexes with P, S-Donor Ligands.钯(II)与P、S供体配体配合物的合成、物理化学表征、生物学评价、计算机模拟和分子对接研究
Pharmaceuticals (Basel). 2023 May 29;16(6):806. doi: 10.3390/ph16060806.
6
Bis(benzonitrile) dichloroplatinum (II) interrupts PD-1/PD-L1 interaction by binding to PD-1.双(苯腈)二氯合铂(II)通过与 PD-1 结合来阻断 PD-1/PD-L1 相互作用。
Acta Pharmacol Sin. 2023 Oct;44(10):2103-2112. doi: 10.1038/s41401-023-01092-9. Epub 2023 May 16.
7
Loss of the volume-regulated anion channel components LRRC8A and LRRC8D limits platinum drug efficacy.LRRC8A 和 LRRC8D 这两种容积调节阴离子通道成分的缺失限制了铂类药物的疗效。
Cancer Res Commun. 2022 Oct 26;2(10):1266-1281. doi: 10.1158/2767-9764.CRC-22-0208.
8
Stimuli-responsive platinum and ruthenium complexes for lung cancer therapy.用于肺癌治疗的刺激响应性铂和钌配合物。
Front Pharmacol. 2022 Oct 17;13:1035217. doi: 10.3389/fphar.2022.1035217. eCollection 2022.
9
Combining Gold Nanoparticles with Other Radiosensitizing Agents for Unlocking the Full Potential of Cancer Radiotherapy.将金纳米颗粒与其他放射增敏剂相结合以释放癌症放射治疗的全部潜力。
Pharmaceutics. 2021 Mar 25;13(4):442. doi: 10.3390/pharmaceutics13040442.
10
The rediscovery of platinum-based cancer therapy.铂类抗癌疗法的再发现。
Nat Rev Cancer. 2021 Jan;21(1):37-50. doi: 10.1038/s41568-020-00308-y. Epub 2020 Oct 30.